MedPath

Tranexamic acid and uterine atony

Not Applicable
Conditions
uterine atony.
Other uterine inertia
O62.2
Registration Number
IRCT20200919048762N2
Lead Sponsor
Yasouj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
140
Inclusion Criteria

Existence of uterine atony based on the surgeon's clinical judgment during the operation (bleeding has been more than 1000 cc and bleeding continues with the help of common methods such as uterine massage and oxytocine)

Exclusion Criteria

History of coagulation, kidney, liver disease
Sensitivity to tranexamic acid
Severe preeclampsia
Thromboembolism
Uncontrolled hypertension
History of heart attack or stroke
History of accreta and increta placenta
Take anticoagulants 24 hours before surgery
Take aspirin 7 days before surgery
Consumption of omega 3 and garlic

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding volume after atony. Timepoint: Immediatly after atony and after intervention. Method of measurement: Per cc and weight of used gazes.
Secondary Outcome Measures
NameTimeMethod
Hemoglobin's changes. Timepoint: 6 hours after bleeding. Method of measurement: gr/dl with Spectrophotometer calibrated.;The need for blood products. Timepoint: After intervention until discharge. Method of measurement: based on unit and signs in surgen's examination or Hemoglobin less than 7.
© Copyright 2025. All Rights Reserved by MedPath